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Rapport de synthèse 
Les profils des granules cytotoxiques des cellules T CDS mémoires sont corrélés à la 
fonction, à leur état de différentiation et à l'exposition à l'antigène. 
Les lymphocytes T-CD8 cytotoxiques exercent leur fonction antivirale et antitumorale surtout 
par la sécrétion des granules cytotoxiques. En général, ce sont l'activité de dégranulation et 
les granules cytotoxiques (contenant perforine et différentes granzymes) qui définissent les 
lymphocytes T-CD8 cytotoxiques. Dans cette étude, nous avons investigué l'expression de 
granzyme K par cytométrie en flux, en comparaison avec l'expression de granzyme A, 
granzyme B et de perforine. L'expression des granules cytotoxiques a été déterminée dans 
lymphocytes T-CD8 qui étaient spécifiques pour des différents virus, en particulier spécifique 
pour le virus d'influenza (flu), le virus Ebstein Barr (EBV), le virus de cytomégalie (CMV) et 
le virus de l'immunodéficience humaine (HIV). Nous avons observé une dichotomie entre 
l'expression du granzyme K et de la perforine dans les lymphocytes T-CD8 qui étaient 
spécifiques aux virus mentionnés. Les profils des lymphocytes T-CD8 spécifiques à flu 
étaient positifs soit pour granzyme A et granzyme K soit pour le granzyme K seul, mais dans 
l'ensemble négatifs pour perforine et granzyme B. Les cellules spécifiques à CMV étaient 
dans la plupart positives pour perforine, granzyme B et A, mais négatives pour le granzyme 
K. Les cellules spécifiques à EBV et HIV étaient dans la majorité positives pour granzyme A, 
B et K, et dans la moitié des cas négatives pour la perforine. 
Nous avons également analysé, selon les marqueurs de mémoire de CD45 et CD127, les 
profils de différentiation cellulaire: Les cellules avec les granules cytotoxiques contenant 
exclusivement le granzyme K, étaient associées à un état de différentiation précoce. Au 
contraire, les protéines cytolytiques perforine, granzyme A et B, correspondent à une 
différentiation avancée. En outre, les protéines perforine et granzyme B, mais pas les 
granzymes A et K, sont corrélées à une activité cytotoxique. Finalement, des changements 
dans l'exposition d'antigène in vitro et in vivo suivant une infection primaire d' HIV ou une 
vaccination modulent le profil de granules cytotoxiques. Ces résultats nous permettent 
d'étendre la compréhension de la relation entre les différents profils de granules cytotoxiques 
des lymphocytes T-CD8 et leur fonction, leur état de différentiation et l'exposition à 
l'antigène. 
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Cytotoxic CD8 T cells exert their antiviral and antitumor activity primarily through the secretion of cytotoxic 
granules. Degranulation activity and cytotoxic granules (perforin plus granzymes) generally define CD8 T cells 
with cytotoxic fonction. In this study, we have investigated the expression of granzyme K (GrmK) in compar-
ison to that of GrmA, GrmB, and perforin. The expression of the cytotoxic granules was assessed in virus-
specific CD8 T cells specific to influenza virus, Epstein-Barr virus (EBV), cytomegalovirus (CMV), or human 
immunodeficiency virus type 1 (HIV-1). We observed a dichotomy between GrmK and perforin expression in 
virus-specific CD8 T cells. The profile in influenza virus-specific CD8 T cells was perforin- GrmB- GrmA +/-
GrmK+; in CMV-specific cells, it was perforin+ GrmB+ GrmA + GrmK-1+; and in EBV- and HIV-1-specific 
cells, it was perforin-/+ GrmB+ GrmA + GrmK+. On the basis of the delineation of memory and effector CD8 
T cells with CD45RA and CD127, the GrmK+ profile was associated with early-stage memory CD8 T-cell 
differentiation, the perforin+ GrmB+ GrmA + profile with advanced-stage differentiation, and the GrmB+ 
GrmA + Grmk+ profile with intermediate-stage differentiation. Furthermore, perforin and GrmB but not 
GrmA and GrmK correlated with cytotoxic activity. Finally, changes in antigen exposure in vitro and in vivo 
during primary HIV-1 infection and vaccination modulated cytotoxic granule profiles. These results advance 
our understanding of the relationship between distinct profiles of cytotoxic granules in memory CD8 T cells 
and fonction, differentiation stage, and antigen exposure. 
The primary fonction of cytotoxic T lymphocytes and natural 
killer cells is to detect and eliminate virus-infected or trans-
formed cells, thus playing a key role in the so-called immuno-
smveillance (6, S, 43). Cytotoxic cells mediate their lytic activ-
ity through two mechanisms: granule-dependent cytotoxicity 
and death-receptor-dependent cytotoxicity (19, 43). The death-
receptor-dependent pathway is activated by the interaction 
between CD95 (FAS), tumor necrosis factor, or TRAIL and 
the cognate ligands expressed on the surfaces of cytotoxic cells. 
The principal cytotoxic mechanism, however, is represented by 
granule-dependent cytotoxicity. The cytotoxic granules contain 
perforin (pore-forming protein) and several granule-associated 
proteases, including the granzymes (3, 11, 19, 35). Five differ-
ent granzymes have been identified in humans: granzyme A 
(GrmA), GrmB, GrmH, GrmK, and GrmM (3, 11, 19, 22, 35). 
Following recognition of the target cells by cytotoxic lympho-
cytes, secretion of the cytotoxic granules is induced, leading to 
the death of the target cells. It has been proposed that perforin 
either destabilizes the plasma membrane, facilitating the inter-
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nalization of the cytotoxic granules into endosomes and the 
subsequent release in the cytoplasm, or colocalizes with the 
granzymes into the endosomes and destabilizes the vesicles to 
allow release of the granzymes in the cytoplasm (14, 42, 57, 5S). 
The granzymes found in humans are all able to induce cell 
death in different experimental models, and they differ in their 
intracellular substrates (11, 19, 35, 36, 51). GrmB is a serine 
protease, and GrmA and -K belong to the tryptase family (11, 
lS, 19, 35, 36, 52, 63). With regard to GrmK, a series of studies 
with mice has shown that GrmK may induce cell death by a 
mechanism that involves the generation of reactive oxygen 
species (37), that GzmK may cause mitochondrial damage 
(62), and that GrmK mimics GrmA DNA damage by inducing 
caspase-independent nuclear fragmentation and nuclear con-
densation and single-stranded DNA breaks (62). Furthermore, 
another study analyzing cytolytic transcriptional profiles (in-
cluding that of GrmK) in influenza virus- and herpes simplex 
virus type 1-specific CDS T cells showed increased expression 
of ail the granzymes during acute infection (3S). GrmB induces 
caspase-dependent apoptosis (49), while GrmA-, GrmH-, 
GrmK- and GrmM-induced death is independent of caspase 
activation (27, 32, 37). Experiments performed with mice have 
provided a direct demonstration of the key role of perforin and 
GrmB in the cytotoxic activity mediated by CDS T cells (30, 31, 
47, 54). Along the same lines, studies performed with human 
CDS T cells support the important role of perforin (61). 
Cytotoxic CDS T cells play a fondamental role in protection 
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T-cell responses following vaccination is thought to be a key 
component of protective immunity (29, 34, 39, 40, 46, 4S). For 
these reasons, several studies have centered on the fonctional 
characterization of CDS T ce!ls with the objective of identify-
ing fonctional profiles that may correlate with protective CDS 
T-cell responses (9, 26, 33, 39, 40, 56). In this regard, ex-
tensive phenotypic and fonctional characterization of Ag-
specific memory CDS T ce!ls has been made with different 
models of virus infection (1, 2, 33, 34, 40, 46, 4S, 56, 60), and 
the term polyfonctional has been used to define T-cell immune 
responses that, in addition to typical effector fonctions such as 
secretion of gamma interferon, tumor necrosis factor alpha, or 
MIP-113 and cytotoxic activity, comprise distinct T-cell popu-
lations also able to secrete interleukin 2 (IL-2) and which 
retain proliferation capacity (9, 26, 39, 40). The polyfonctional 
profile of CDS T cells has been associated with protective 
antiviral immunity (9, 26, 39, 40). Of note, it has been sug-
gested that antigen (Ag) exposure/persistence or Ag levels 
substantially influenced the fonctional and phenotypic profiles 
of T-cell responses (26, 39, 40). 
Severa! studies have previously analyzed the distribution of 
cytotoxic granules, and it has been shown that perforin and 
GrmB are predominantly expressed in CDS T cells with effec-
tor fonction whereas GrmA expression appears to be more 
ubiquitous (2, S, 16, 35, 50, 57). However, the distribution of 
GrmK has never been investigated, nor has the simultaneous 
expression of perforin and GrmA, GrmB, and GrmK in several 
models of virus infection, including influenza virus, Epstein-
Barr virus (EBV), cytomegalovirus (CMV), and human immu-
nodeficiency virus type 1 (HIV-1). 
In the present study, we have performed a comprehensive 
characterization of virus-specific CDS T-cell responses against 
HIV-1, CMV, EBV, and influenza virus in order to carry out 
the fo!lowing: (i) analysis of the profiles of cytotoxic granules, 
including perforin and granzymes (GrmA, -B, and -K), in dif-
ferent models of virus-specific CDS T-cell responses, (ii) anal-
ysis of the relationship between cytotoxic granule profiles and 
cytotoxic activity, proliferation capacity, and differentiation 
stage of CDS T cells, and (iii) kinetic studies of the distribution 
of cytotoxic granules in HIV-1-specific CDS T-cell responses 
during primary infection and following vaccination. 
MATERIALS AND METHODS 
Study groups. Seventeen subjects with progressive chronic or primary HIV-1 
infection were investigated prior to their enrolment in clinical trials including 
antiviral therapy with nucleoside and protease inhibitors (7). In patients with 
chronic HIV-1 infection, at baseline (prior to the initiation of antiviral therapy), 
CD4 T-cell counts (mean ± standard error) were 790 ± 241 cells/µl and plasma 
viremia was 4.39 ± 043 log10 HIV-1 RNA copies/ml. Regarding patients with 
primary HIV-1 infection, primary HIV-1 infection was diagnosed on the basis of 
the presence of an acute clinical syndrome, a negative HIV-1 antibody test, a 
positive test for HIV-1 RNA in plasma, and a presence of fewer than three 
positive bands in a Western blot. In addition, blood from 39 HIV-negative 
subjects was obtained either from the local blood bank (Lausanne, Switzerland) 
or from !ab coworkers. Pive volunteers enrolled in the EV02 HIV vaccine clinical 
trial were also studied (24). These studies were approved by the Institutional 
Review Board of the Centre Hospitalier Universitaire Vaudois. 
Synthetic peptides and peptide-major histocompatibility complex (MHC) 
class 1 tetramer complexes. Ali the peptides used in this study were high-
performance liquid chromatography purified (>S0% purity). HLA-A2-GILG 
FVFTL (influenza virus), -GLCTLVAML (EBV), -NLVPMVATV (CMV), 
-SLYNTVATL (HIV Gag), and -ILIŒPVHGV (HIV Pol) and HLA-A*Olül-
YSENSSEYY (HIV Env) peptide-MHC class I tetramer complexes were pur-
chased from Beckman Coulter (Fullerton, CA); HLA-B*0701/02-GPGH 
KARVL (HIV Gag) and HLA-B*OSOl-RAFKQLL (EBV) peptide-MHC class I 
tetramers complexes were produced as described previously (15). 
Antibodies. The following antibodies were used in different combinations. 
CDS-PerCPCy5.5, CD45RA-PECy5, and GrmB-AF700 were purchased from 
BD (Becton Dickinson, San Diego, CA), GrmA-PB from Biolegend (San Diego, 
CA), CD27-APC and CD127-PECy7 from eBioscience lnc. (San Diego, CA), 
CCR7-FITC and CD127-APC from R&D Systems (Minneapolis, MN), CD3-
Qdot655 from Invitrogen (Carlsbad, CA), and GrmK-FITC from Santa Cruz 
Biotechnology (Santa Cruz, CA). 
Ex vivo analysis of virus-specific CDS T cells. Cryopreserved blood mononu-
clear cells (1 X 106 to 2 X 106) were stained with appropriate titers of peptide-
MHC class I tetramer complexes at 4°C for 15 min and then either permeabilized 
(Cytofix/Cytoperm; BD) and stained at room temperature for 20 min with 
GrmK, GrmA, GrmB, perforin, CD45RA, CD127, and CDS or directly stained 
at 4°C for 20 min with CD3, CDS, CD45RA, CD127, CD27, and CCR7. Cells 
were then fixed with CellFix (BD), acquired on an LSRII SORP flow cytometer 
(four lasers), and analyzed using the FlowJo S.7.1 (Tree star lnc., Ashland, OR) 
and SPICE 4.1.5 (developed by Mario Roederer, Vaccine Research Center, 
NIAID, NIH) software programs. The number of lymphocyte-gated events 
ranged between 6 X 105 and 106 in the flow cytometry experiments. 
Ex vivo proliferation assay. Cryopreserved blood mononuclear cells (1 X 106 
in 1 ml of complete medium) were cultured in the presence of anti-CD2S 
antibody (0.5 µg/ml; BD), 50 UI of IL-2 (Proleukin; Novartis International, 
Base!, Switzerland) and 1 µg/ml of peptide as described previously (25, 64). At 
day 7, ce lis were harvested, stained with appropriate titers of peptide-MHC class 
I tetramer complexes at 4°C for 15 min, and then permeabilized (Cytofix/Cyto-
perm; BD) and stained at room temperature for 20 min with GrmK, GrmA, 
GrmB, perforin, CD45RA, CD127 and CDS. Cells were then acquired on an 
LSRII SORP flow cytometer (4 lasers) and analyzed using FlowJo S.7.1 and 
SPICE 4.1.5 (developed by Mario Roederer, Vaccine Research Center, NIAID, 
NIH). 
Chromium release assay. T2 cells were used as targe! cells in standard 51 Cr 
release assays as described previously (21 ). 51 Cr labeling and pu Ising with cog-
nate peptide (or an irrelevant HIV peptide for a contrai) was performed for 1 h 
at 37°C. Two thousand, five hundred target cells were aliquoted into microtiter 
plates. CD4- and CD19-depleted peripheral blood mononuclear CDS T cells 
were added to the targets at 50:1, 25:1, 12:1, and 6:1 ratios. Assay plates were 
incubated for 4 h at 37°C in 5% C02 before harvest. Specific 51 Cr release was 
calculated from the following equation: [(experimental release - spontaneous 
release)/(maximum release - spontaneous release)] X 100%. 
Statistical analysis. The statistical significance (P values) of the results was 
calculated by using a two-tailed Student t test using either the Excel (Microsoft, 
Redmond, WA) or SPICE 4.1.5 software program. A two-tailed P value of less 
than 0.05 was considered significant. The correlations among variables were 
tested by simple regression analysis. 
RESULTS 
Profile of cytotoxic-granule distribution in virus-specific 
CDS T cells. To determine the profiles of cytotoxic-granule 
distribution, influenza virus-, EBV-, CMV-, and HIV-1-specific 
CDS T cells were detected by peptide-HLA tetramer com-
plexes and simultaneously stained with perforin, GrmA, 
GrmB, and GrmK antibodies using polychromatic flow cytom-
etry. The analysis was limited to GrmA, -B and -K, since 
monoclonal antibodies for GrmH and-Mare not available. In 
the representative examples shown in Fig. lA, perforin and 
GrmB expression was almost absent in influenza virus-specific 
CDS T ce!ls whereas a larger percentage, ranging between 60 
and SO%, expressed GrmA and GrmK. About 10% of EBV-
specific CDS T cells expressed perforin, and larger percentages 
expressed GrmB (about 50%) and GrmA and -K (about SO%) 
(Fig. lA). About 40% of CMV-specific CDS T cells expressed 
perforin, about 60% expressed GrmB and GrmA, and about 
40% expressed GrmK (Fig. lA). About 10% of HIV-1-specific 
CDS T cells expressed perforin, whereas a larger percentage of 
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FIG. 1. Perforin and GrmB, -A, and -K expression in virus-specific CDS T-cells. (A) Representative ftow cytometry profiles of perforin and 
GrmB, -A, and -K expression in influenza virus- (Flu), EBV-, CMV-, and HIV-1-specific CDS T cells. (B) Simultaneous analysis of the 
cytotoxic-granule composition of virus-specific CDS T cells on the basis of perforin, GrmB, GrmA, and GrmK expression. Ali the possible 
combinations of the different markers are shown on the x axis, whereas the percentage of the perforin/granzyme distinct cell subsets within 
virus-specific CDS T-cell populations are shown on the y axis. The pie charts summarize the data, and each slice corresponds to the proportion 
of virus-specific CDS T cells positive for a certain combination of mark ers. Only significant differences of a given virus-specific CDS T-cell response 
versus ail the others are shown. At least 600,000 live gated events were acquired. 
GrmK (about 50%). The profile of perforin and the percent-
ages of positive cells observed in HIV-1- and CMV-specific 
CD8 T cells in our study (Fig. lA) are identical to those shown 
in two previous publications (2, 61 ). Perforin unfortunately 
does not consistently have a bimodal distribution, particularly 
in virus-specific CD8 T cells, and this is the reason why in our 
report and the two previous reports the gates for perforin 
appear in the middle of a population in some cases. With 
regard to the different percentages of cytotoxic-granule expres-
sion in different populations of virus-specific CD8 T cells, it is 
also important to underscore that these changes truly reflect 
immunologically relevant changes. In this regard, it is worth 
mentioning that ail the experiments with tetramers were per-
formed using Ca2 + -free medium and ail our tetramers have 
been tested using both the 4°C and 37°C experimental condi-
tions. As shown in the additional data attached (see Data Sl in 
the supplemental material), the percentages of tetramer-posi-
tive cells for HIV-, CMV-, EBV-, and influenza virus-specific 
CD8 T cells are almost identical under the two experimental 
conditions. Therefore, the changes in cytotoxic-granule pro-
files among the virus-specific CD8 T-cell populations are not 
the result of unstable tetramer expression due to T-cell recep-
tor downregulation or to modifications in the content of cyto-
toxic granules following degranulation. 
The profiles of cytotoxic-granule distribution within virus-
specific CD8 T cells were confirmed by the analysis of 49 
individual virus-specific CD8 T-cell responses, and we then 
analyzed the simultaneous expression of perforin and gran-
zymes in the different virus-specific CD8 T cells. This analysis 
showed first that about 40% of influenza virus-specific CD8 T 
cells did not express either perforin or granzymes, compared to 
10 to 20% of the other virus-specific CD8 T cells (Fig. lB). 
These differences were statistically significant (P < 0.01). The 
remaining influenza virus-specific CD8 T cells expressed single 
GrmK+ or dual GrmK+ GrmA + cells (>90% of cells) (Fig. 
lB). EBV- and HIV-1-specific CD8 T cells had similar profiles 
of perforin and granzyme expression (Fig. lB); about 50% of 
CD8 T cells were singly GrmK+ or dually GrmK+ GrmA +, 
about 30% triply GrmK+ GrmA + GrmB+; only a minority 
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cMV-specific CD8 T cells contained cell populations express-
ing perforin and/or GrmB (Fig. lB). The profiles of cytotoxic 
granules in the different virus-specific CD8 T cells were signif-
icantly different (P < 0.01), with the exception of those for 
EBV and HIV-1 (P > 0.05). 
Taken together, these results indicate substantial differences 
in the profiles of cytotoxic-granule distribution among different 
virus-specific CD8 T cells. 
Relationship between cytotoxic granules and dilferentiation 
stage of memory CDS T cells. We next addressed the relation-
ship between the profiles of cytotoxic-granule distribution and 
the stage of differentiation of virus-specific CD8 T cells. For 
these purposes, virus-specific CD8 T cells were stained with a 
panel of markers used to identify functionally distinct popula-
tions of memory CD8 T cells at different stages of differenti-
ation . These markers included CD45RA, CD28, CD27, CD127 
and CCR7 (15, 33, 34, 44, 45, 56, 64). 
As previously shown (1, 17, 26), this analysis confirmed the 
lack of an overlap between the different markers, and up to 10 
different populations of virus-specific CD8 T cells were iden-
tified when ail markers were analyzed simultaneously (data not 
shown). Based on this observation, we investigated which com-
bination of markers was the most suitable to better identify 
differences in the differentiation stages of the CD8 T cells 
specific to HIV, EBV, CMV, and influenza virus. In particular, 
we wanted to identify differentiation markers that can discrim-
inate between memo1y CD8 T-cell populations specific to vi-
ruses that are efficiently cleared, such as influenza virus, and to 
those (predominantly effector CD8 T-cell populations) specific 
to viruses that persist and are poorly controlled, such as HIV-1. 
Consistent with previous studies (1 , 26, 33), the large ma-
jority (> 70%) of influenza virus-, EBV-, and HIV-1-specific 
CD8 T cells were CD45RA - CD2r white the distribution of 
these markers was quite heterogeneous in CMV-specific CD8 
T cells, which were characterized by a large percentage of 
CD45RA + cells (Fig. 2A; see Data S2 in the supplemental 
material). Ail the four virus-specific CD8 T-cell populations 
were CCRT, and with the exception of CMV-specific CD8 T 
cells, ofwhich a substantial percentage were CD45RA + (about 
50% ), were also CD45RA - (Fig. 2A; see Data S2 in the sup-
plemental material). The large majority (about 80%) of influ-
enza virus-specific CD8 T cells were CD12r, white about 80% 
of HIV-1-specific CD8 T cells were CD12T (Fig. 2A and B). 
CD127 was expressed on about 50% and 30% of EBV- and 
CMV-specific CD8 T cells, respectively (Fig. 2A and B). Con-
sistent with previous studies, our results indicated that CD127 
is very instrumental for discriminating between memory and 
effector CD8 T-cell populations at different stages of differen-
tiations, the expression being associated with an early stage 
and the lack of expression to a more advanced stage ( 4, 10, 28, 
55, 59). 
Therefore, the CD127 and CD45RA combination appeared 
to be more suitable for assessing the diversity of the differen-
tiation stage of the different memo1y virus-specific CD8 T cells, 
and for these reasons, this combination was used in the sub-
sequent experiments. 
Cytotoxic granule distribution was then determined within 
the three CD8 T-cell memory populations defined by the ex-
pression of CD127 and CD45RA. The preliminary analyses 
were performed with total blood CD8 T cells. The analysis of 
the expression of GrmA versus that of GrmB and of that of 
GrmK versus that of perforin within the CD12r CD45RA - , 
CD12T CD45RA- , and CD12T CD45RA + CD8 T-cell pop-
ulations indicated that a large proportion of memory CD8 T 
cells coexpressed GrmA and GrmB and that the percentage of 
cells positive for these cytotoxic granules increased with the 
progression of cell differentiation (see Data S3 in the supple-
mental material). GrmA and GrmB were coexpressed in about 
80% of terminally differentiated CD12TCD45RA + CD8 T 
cells (see Data S3 in the supplemental material). Furthermore, 
GrmK and perforin were expressed in memory CD8 T-cell 
populations at different stages of differentiation but were vir-
tually never coexpressed (see Data S3 in the supplemental 
material). The simultaneous analysis of granzymes and per-
forin allowed a better appreciation of the relationship between 
the profiles of cytotoxic-granule distribution and memory CD8 
T-cell differentiation. The early-stage-differentiation CD127+ 
CD45RA - CD8 T-cell population contained predominantly 
GrmK and GrmA, whereas GrmB and perforin were almost 
absent (see Data S3 in the supplemental material). The inter-
mediate-stage-differentiation CD12T CD45RA - CD8 T-cell 
population contained higher levels of GrmA (about 80%) and 
GrmB (about 70%) than of GrmK (about 50%) and perforin 
(about 25 %) (see Data S3 in the supplemental material). The 
terminally differentiated CD12T CD45RA + cells contained 
comparable high levels of perforin, GrmA, and GrmB (about 
50 to 60% ), consistent with recently published results from a 
study using CD57 as a marker of differentiated cells (16) . 
However, GrmK was almost absent in differentiated cells (see 
Data S3 in the supplemental material). 
The profiles of cytotoxic-granule distribution observed in 
total memory CD8 T-cell populations were then confirmed 
with virus-specific CD8 T cells. On the basis of the ana lysis of 
35 virus-specific CD8 T-cell responses specific to influenza 
virus, EBV, CMV, and HIV-1, GrmK was contained predom-
inantly within the CD12r CD45RA - CD8 T-cell population 
(Fig. 2C). In addition, CD127 + CD45RA- CMV-specific CD8 
T cells also contained perforin (Fig. 2C). GrmA and GrmB 
were contained predominantly within the CD12T CD45RA-
CD8 T-cell population (Fig. 2C). CD12T CD45RA- CMV-
specific CD8 T-cell populations had higher percentages of per-
forin + cells (Fig. 2C). Finally, the CD12TCD45RA + CMV-
specific CD8 T-cell population contained the highest 
percentage (about 90%) of CD8 T cells expressing perforin 
and/or GrmB (Fig. 2C). The profiles of cytotoxic granules 
between the different virus-specific CD8 T cells within the 
CD12r CD45RA - and CD12T CD45RA - cell populations 
were significantly different (P < 0.01), with the exception of 
those for EBV and HIV-1 (P > 0.05). 
Relationship between profiles of cytotoxic granules and Ag 
exposure in vitro and in vivo. The relationship between Ag 
exposure &nd the profiles of cytotoxic granules was then inves-
tigated and was first determined in vitro. For this purpose, the 
profile of cytotoxic granules was compared in the same samples 
either ex vivo in unstimulated cell populations or in vitro 7 days 
after Ag-specific stimulation. Subject no. 1 was very instrumen-
tal, since he had CD8 T cells specific to influenza virus-, EBV-, 
and CMV-derived peptides restricted by HLA-A2. Simulta-
neous analysis of the cytotoxic granules in the influenza virus-, 
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FIG. 2. Phenotypic analyses of virus-specific CDS T cells, defined by CD27, CCR7, CD127, and CD45RA expression . (A) Representative ftow 
cytometry profiles of MHC class I peptide tetramer complexes specific to influenza virus (Flu), EBV, CMV, or HIV-1 epitope (top panel) and 
expression of CD45RA versus that of CD27, CCR7, or CD127 in total CDS T cells (left panels) or in virus-specific CDS T cells (right panels). 
(8) Cumulative data on the distribution of virus-specific CDS T cells in the different T-cell subsets defined by CD45RA and CD127. Asterisks 
indicate significant differences of a given virus-specific CDS T-cell response versus ail the others. (C) Cumulative analysis of the simultaneous 
expression of perforin and GrmB, -A, and -K in different virus-specific CDS T cells defined by the expression of CD45RA and CD127. Only 
relevant CDS T-cell populations are shown for each virus-specific CDS T-cell response. Each slice corresponds to the proportion of virus-specific 
CDS T cells positive for a certain combinat ion of perforin/granzyme expression. Only the populations positive for at least one marker (i.e., perforin 
or GrmB, -A, or -K) are shown. At least 600,000 live gated events were acquired. 
typical profile of higher GrmK and GrmA expression in influ-
enza virus-specific CD8 T cells, higher perforin and GrmB 
expression in CMV-specific CD8 T cells, and comparable 
GrmA, -B, and -K expression and lower perforin expression in 
EBV-specific CD8 T cells (Fig. 3A and B). Flow cytometry 
profiles of cytotoxic granules are shown only for influenza 
virus-specific CD8 T cells (Fig. 3A). 
Blood mononuclear cells from subject no. 1 were then stim-
ulated for 7 days with the influenza virus-, EBV-, and CMV-
derived peptides, and the stimulated cultures were assessed for 
the profile of cytotoxic granules at the end of the stimulation 
period. Simultaneous analysis of the cytotoxic granules in the 
influenza virus-, EBV-, and CMV-specific CD8 T-cell popula-
tions showed major changes in the expression of the different 
cytotoxic granule profiles. As shown in Fig. 3A, in vitro expan-
sion of the influenza virus-specific CD8 T cells induced an 
important upregulation of perforin, GrmA, and GrmB and a 
downregulation of GrmK. Of note, similar changes occurred 
for EBV- and CMV-specific CD8 T cells (Fig. 3B). Further-
more, the changes in the profiles of cytotoxic granules after 
Ag-specific stimulation were confirmed by the analysis of 20 
virus-specific CD8 T-cell responses (Fig. 3C). The profiles of 
cytotoxic granules were significantly different after expansion 
from those analyzed directly ex vivo (P < 0.01 for ail three 
viruses). 
These rnsults clearly indicated that Ag reexposure/stimula-
tion in vitro was associated with the increased expression of 
perforin, GrmA, and GrmB and with the decreased expression 
of GrmK. 
We then investigated whether similar changes in the cyto-
toxic-granule profiles occurred in vivo. For these purposes, we 
monitored the changes in cytotoxic granules occurring during 
primary HIV-1 infection and following vaccination with the 
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FIG. 3. Relationship between the profiles of cytotoxic granules and Ag exposure in vitro.(A) Representative How cytometry profiles of the 
expression of perforin, GrmB, GrmA, and GrmK on te tramer+ CDS T cells from subject no. 1 directly ex vivo (red histograms) or after 7 days 
of in vitro expansion (blue histograms). Flu, influenza virus specificity. (B) Analysis of the simultaneous expression of GrmA, -B, -K, and perforin 
in influenza virus- , EBV-, or CMV-specific CDS T cells from subject no. 1 directly ex vivo (left panel) or after 7 days of in vitro stimulation (right 
panel) . (C) Cumulative data on the simultaneous expression of perforin and GrmB, -A, and -K in virus-specific CDS T cells after 7 days of in vitro 
stimulation. Ali the possible combinations of the different markers are shown on thex axis, whereas the percentages of perforin/granzyme distinct 
cell populations within virus-specific CDS T cells are shown on the y axis. The pie charts summarize the data , and each slice corresponds to the 
proportion of virus-specific CDS T cells positive for a certain combination of perforin/granzymes. 
bination (24). At the time of the diagnosis of prima1y HIV-1 
infection , patient no. 1016 had high Ievels ofviremia (2,320,000 
HIV-1 RNA copies per ml). At this time point, the large 
majority (about 70%) of HIV-1-specific CD8 T cells recogniz-
ing the Gag SLYNTVATL epitope restricted by HLA-A *0201 
coexpressed perforin and GrmB and Iower ( 40 to 50%) Ievels 
of GrmK and -A (Fig. 4A). The patient was treated with 
antiviral therapy, and the viremia Ievels have remained stably 
below 50 HIV-1 RNA copies per ml of plasma. Three years 
Iater, after constant virus suppression, perforin expression was 
substantially reduced (18%) and only 37% of CD8 T cells were 
GrmB positive, whereas there was a substantial increase (70%) 
in Gag-specific CD8 T cells coexpressing GrmK and -A (Fig. 
4A). These obseivations were confirmed for several subjects, 
and the cumulative analysis clearly show a significant (P < 
0.01) downregulation of perforin and/or GrmB and an upregu-
Iation of GrmA- and/or GrmK-positive HIV-1-specific CD8 T 
cells after viral suppression (Fig. 4A). 
CD8 T-cell responses specific to an HIV envelope peptide 
(YSENSSEYY) restricted by HLA-A *0101 were characterized 
in a group of healthy volunteers enrolled in the EV02 phase I 
clinical trial evaluating the safety and immunogenicity of a 
candidate HIV vaccine combination (DNA C at weeks 0 and 4, 
followed by NYV AC C at weeks 20 and 24) (24). Represen-
tative (one out of five) ftow cytometry profiles of volunteer no. 
16 are shown in Fig. 4B. At week 26, i.e. , 2 weeks after the last 
immunization, about 65% of Env-specific CD8 T cells coex-
pressed perforin and GrmB and about 40 to 50% GrmK and 
GrmA (Fig. 4B). At week 72, i.e., 48 weeks after the Iast 
immunization, perforin expression was very low and GrmB 
expression substantially reduced (Fig. 4B). The simultaneous 
analysis of the cytotoxic granules at different time points after 
vaccination showed that there was a progressive shift from 
perforin/GrmB-positive Env-specific CD8 T cells to perforin-
low;GrmB1°'v GrmNGrmK11 ig h cells (Fig. 4B). 
These results indicated that Ag exposure modulated cyto-
toxic granule profiles both in vitro and in vivo. 
Relatio~1ship between profiles of cytotoxic granules and 
cytotoxic activity. The relationship between the profiles of 
cytotoxic granules and cytotoxic activity was determined ex 
vivo on freshly isolated blood mononuclear cells using the 
conventional 51Cr release assay. Thus, cytotoxic activity was 
determined on HIV-1-negative subjects with known influenza 
virus-, EBV-, and CMV-specific CD8 T-cell responses. As 
shown in Fig. 5A, cytotoxic activity was determined for subjects 
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FIG. 4. Modulation of the cytotoxic granule profiles by Ag exposure in vivo. (A) Flow cytometry profiles of perforin and granzyme expression, 
perforin versus GrmB and GrmK versus GrmA, in HIV-1 Gag-specific CD8 T cells at the time of the diagnosis of primary HIV-1 infection and 
3 years later (after effective control of HIV-1 replica tion). Cumulative analysis of the simultaneous expression of perforin, GrmB, GrmA, and 
GrmK in dilferent HIV-1-specific CD8 T cells is also shown (11 = 5). SE, standard error. (B) Flow cytometry profiles of perforin and granzyme 
expression, perforin versus GrmB and GrmK versus GrmA, in HIV-1 Env-specific CD8 T cells at dilferent time points following vaccination with 
the DNA C/NYVAC C candidate vaccine combination. Cumulative analysis of the simultaneous expression of perforin, GrmB, GrmA, and GrmK 
in dilferent HIV-1 Env-specific CD8 T cells is also shown. Each slice corresponds to the proportion of virus-specific CDS T cells positive for a 
certain combination of perforin/granzyme expression. Asterisks indicate significant differences for a given Env-specific CDS T-cell population at 
a certa in time point versus all the others. 
sponses, respectively. The profiles of cytotoxic granules for 
these subjects were typical of CMV-specific (i.e., large amounts 
of cells expressing perforin, GrmB, and GrmA and a few cells 
expressing GrmK) and EBV-specific (i.e. , large amounts of 
cells expressing GrmA and GrmK but a few cells expressing 
GrmB and virtually no cells expressing perforin) CD8 T-cell 
responses (Fig. SA). Of interest, direct cytotoxic activity was 
detected only against target cells pulsed with CMV- but not 
EBV-derived peptides (Fig. SB). 
These results clearly indicated that expression of perforin 
and GrmB was associated with cytotoxic activity. Based on 
these results, we determined whether there was a hierarchy 
among the cytotoxic granules in conferring better cytotoxic 
activity to CD8 T cells. We found a strong correlation between 
perforin expression and the magnitude of cytotoxic activity 
mediated by CD8 T cells (Fig. SC). A good correlation was 
found between GrmB and the magnitude of cytotoxic activity 
(Fig. SC). The correlation was not found for GrmA, and a 
negative correlation was found between GrmK expression and 
cytotoxic activity (Fig. SC). 
DISCUSSION 
Cytotoxic CD8 T cells play a fondamental protective rote in 
immunosurveillance against viral infections and tumors and 
are thought to represent a key component of the protective 
immunity induced by vaccines (6, 40, 43, 47). The cytotoxic 
fonction is the primary mechanism of CD8 T cells to mediate 
protection, and cytotoxic fonction is exerted predominantly 
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GrmK. The percentage of specific lysis is shown on the x axis and is correlated with the expression of each of the different markers. 
reasons, it is important to delineate the relationship between 
cytotoxic granules and cytotoxic activity. In this regard, CD8 T 
cells from perforin-deficient mice have impaired cytotoxic 
fonction, and these mice are severely immunosuppressed (30). 
Furthermore, granzyme-deficient mice have also shown abnor-
malities of the CD8 T-cell cytotoxic fonction and association 
with various degrees of immunodeficiency (19). 
A series of studies has previously investigated the profiles of 
cytotoxic-granule distribution in human CD8 T cells, and some 
patterns of cytotoxic-granule distribution have been shown to 
preferentially associate with certain stages of differentiation 
and cytotoxic activity (2, 5, 12, 16, 23, 35, 50, 61). 
In the present study, we have investigated the distribution of 
GrmK in different populations of virus-specific CD8 T cells, 
the relationship between Grmk, GrmA, GrmB, and perforin 
expression, the relationship between GrmK and cytotoxic ac-
tivity, the relationship with the differentiation stage of CD8 T 
cells, and the modulation of cytotoxic-granule expression and 
Ag exposure in vitro and ex vivo. 
Distinct profiles of perforin and granzyme distribution 
were associated with the different virus-specific CD8 T-cell 
responses. Influenza virus- and CMV-specific CD8 T cells had 
very divergent profiles, with the former being characterized by 
high levels of expression of GrmK and almost no perforin and 
GrmB and the latter by high perforin/GrmB expression and 
low GrmK. HIV-1- and EBV-specific CD8 T cells had an 
intermediate (compared to influenza virus and CMV) cytotoxic-
granule profile, with high levels of expression of GrmA, -Band 
-K and low levels of perforin. According to previous studies, 
perforin expression was deficient in HIV-1-specific T cells 
compared to that in CMV-specific CD8 T cells (2) . 
The present results indicate a dichotomy in the expression of 
GrmK versus that of perforin. We were therefore interested in 
determining the profile of expression of GrmK versus that of 
perforin in virus-specific CD8 T cells at different stages of 
differentiation. We assessed a series of mem01y markers, in-
cluding CD27, CCR7, and CD127, in combination with 
CD45RA in order to define different populations of memory 
and effector CD8 T cells. We selected CD127 in combination 
with CD45RA since CD127 was the only marker, compared to 
CD27 and CCR7, providing a clear, distinct expression profile 
in influenza virus-specific CD8 T cells, which are a remnant of 
efficient virus clearance, and HIV-1-specific CD8 T cells, which 
are associ:ited with persistence and uncontrolled virus replica-
tion . On the basis of previous studies with mice and humans, it 
appears that the CD45RA/CD127 combination provides a bet-
ter definition of the differentiation stage of memory virus-
specific CD8 T cells compared to the different combinations of 
CD45RA with CD27 or CCR7 (28, 29, 34, 46, 60). 
Our findings indicate a clear distinct profile of GrmK ex-
pression versus perforin expression in memory and effector 


































2870 HARAR! ET AL. 
defined by CD45RA and CD127 of CD8 T cells (28, 29, 34, 46, 
60). The GrmK+ profile was associated with memory CD8 T 
cells at early-stage differentiation (CD127+ CD45RA - ), while 
the perforin + (and also GrmB+) profile was associated with 
cells at advanced-stage differentiation (CD12T CD45RA +) . 
The GrmA +, -B+ and -K+ profile was found in CD8 T cells at 
intermediate-stage differentiation (CD12T CD45RA - ). 
Perforin expression was barely detected in CD8 T cells at 
early-stage differentiation and was found at low levels at 
intermediate-stage differentiation, while GrmA was ex-
pressed at ail differentiation stages. Of note, according to re-
cent studies, perforin expression was enriched in differentiated 
cells (16, 50). 
Having established the relationship between distinct profiles 
of cytotoxic granules and differentiation stages, we determined 
their correlation with the cytotoxic function . The results ob-
tained contribute to further consolidating the relationship be-
tween cytotoxic-granule profiles and CD8-T-cell-mediated cy-
totoxic function and demonstrate a hierarchy among the 
cytotoxic granules. Perforin was the most powerful correlate of 
cytotoxic function, followed by GrmB. Interestingly, GrmA did 
not correlate with cytotoxic function, whereas GrmK was neg-
atively correlated. GrmK, however, correlated with the per-
centage of CD12r CD8 T cells, which in turn is correlated 
with the proliferation capacity (data not shown). 
Of interest, the results obtained in vitro and in vivo clearly 
demonstrated that Ag exposure inftuenced cytotoxic-granule 
profiles and thus also cytotoxic activity of CD8 T-cells. Poorly 
cytotoxic profiles were observed in models of low or absent Ag 
Joad, such as influenza virus infection or vaccine-induced T-cell 
responses or after effective contrai of HIV-1 replication. These 
situations were associated with high expression levels of 
CD127 and therefore with a high proliferation capacity (data 
not shown) . In contrast, highly cytotoxic profiles were observed 
in vitro following Ag reexposure or in vivo during acute HIV-1 
infection or at the peak of the immune response following 
immunization. Therefore, these observations should be taken 
into account for a correct evaluation of the cytotoxic function 
of CD8 T cells. However, it is important to underscore that in 
certain virus infections, such as HIV infection, defective cyto-
toxic activity and low perforin levels are found despite high Ag 
levels and may result from mechanisms such as skewed matu-
ration (15), senescence (13), and exhaustion (20, 41 , 53). 
In conclusion, these data provide two distinct markers to 
delineate noncytotoxic, i.e., GrmK-expressing, and cytotoxic, 
i.e., perforin-expressing, CD8 T cells and are therefore instru-
mental for developing appropriate strategies to monitor mem-
ory cytotoxic CD8 T-cell responses in viral infections and can-
cer and following vaccination. 
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